Author
Listed:
- Pierre Martinez
(Evolution and Cancer Laboratory, Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London)
- Margriet R. Timmer
(Academic Medical Center—University of Amsterdam
Center for Experimental and Molecular Medicine, Academic Medical Center—University of Amsterdam)
- Chiu T. Lau
(Academic Medical Center—University of Amsterdam
Center for Experimental and Molecular Medicine, Academic Medical Center—University of Amsterdam)
- Silvia Calpe
(Academic Medical Center—University of Amsterdam
Center for Experimental and Molecular Medicine, Academic Medical Center—University of Amsterdam)
- Maria del Carmen Sancho-Serra
(Academic Medical Center—University of Amsterdam
Center for Experimental and Molecular Medicine, Academic Medical Center—University of Amsterdam)
- Danielle Straub
(Academic Medical Center—University of Amsterdam
Center for Experimental and Molecular Medicine, Academic Medical Center—University of Amsterdam)
- Ann-Marie Baker
(Evolution and Cancer Laboratory, Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London)
- Sybren L. Meijer
(Academic Medical Center—University of Amsterdam)
- Fiebo J. W. ten Kate
(Academic Medical Center—University of Amsterdam)
- Rosalie C. Mallant-Hent
(Flevoziekenhuis
Gastroenterological Association)
- Anton H. J. Naber
(Gastroenterological Association
Tergooiziekenhuizen)
- Arnoud H. A. M. van Oijen
(Gastroenterological Association
Medisch Centrum)
- Lubbertus C. Baak
(Gastroenterological Association
Onze Lieve Vrouwe Gasthuis)
- Pieter Scholten
(Gastroenterological Association
Sint Lucas Andreas Ziekenhuis)
- Clarisse J. M. Böhmer
(Gastroenterological Association
Spaarne Ziekenhuis)
- Paul Fockens
(Academic Medical Center—University of Amsterdam)
- Jacques J. G. H. M. Bergman
(Academic Medical Center—University of Amsterdam
Gastroenterological Association)
- Carlo C. Maley
(Biodesign Institute, School of Life Sciences, Arizona State University)
- Trevor A. Graham
(Evolution and Cancer Laboratory, Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London)
- Kausilia K Krishnadath
(Academic Medical Center—University of Amsterdam
Center for Experimental and Molecular Medicine, Academic Medical Center—University of Amsterdam
Gastroenterological Association)
Abstract
Surveillance of Barrett’s oesophagus allows us to study the evolutionary dynamics of a human neoplasm over time. Here we use multicolour fluorescence in situ hybridization on brush cytology specimens, from two time points with a median interval of 37 months in 195 non-dysplastic Barrett's patients, and a third time point in a subset of 90 patients at a median interval of 36 months, to study clonal evolution at single-cell resolution. Baseline genetic diversity predicts progression and remains in a stable dynamic equilibrium over time. Clonal expansions are rare, being detected once every 36.8 patient years, and growing at an average rate of 1.58 cm2 (95% CI: 0.09–4.06) per year, often involving the p16 locus. This suggests a lack of strong clonal selection in Barrett’s and that the malignant potential of ‘benign’ Barrett’s lesions is predetermined, with important implications for surveillance programs.
Suggested Citation
Pierre Martinez & Margriet R. Timmer & Chiu T. Lau & Silvia Calpe & Maria del Carmen Sancho-Serra & Danielle Straub & Ann-Marie Baker & Sybren L. Meijer & Fiebo J. W. ten Kate & Rosalie C. Mallant-Hen, 2016.
"Dynamic clonal equilibrium and predetermined cancer risk in Barrett’s oesophagus,"
Nature Communications, Nature, vol. 7(1), pages 1-10, November.
Handle:
RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms12158
DOI: 10.1038/ncomms12158
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Mohammadamin Edrisi & Xiru Huang & Huw A. Ogilvie & Luay Nakhleh, 2023.
"Accurate integration of single-cell DNA and RNA for analyzing intratumor heterogeneity using MaCroDNA,"
Nature Communications, Nature, vol. 14(1), pages 1-15, December.
- S J M Hoefnagel & N Mostafavi & M R Timmer & C T Lau & S L Meijer & K K Wang & K K Krishnadath, 2020.
"A genomic biomarker-based model for cancer risk stratification of non-dysplastic Barrett’s esophagus patients after extended follow up; results from Dutch surveillance cohorts,"
PLOS ONE, Public Library of Science, vol. 15(4), pages 1-17, April.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms12158. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.